This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of bioactive molecules. It serves as a key intermediate in the creation of compounds targeting neurological disorders, such as anxiety, depression, and schizophrenia, due to its structural compatibility with receptors in the central nervous system. Additionally, it is employed in the development of enzyme inhibitors, leveraging the trifluoromethyl group to enhance binding affinity and metabolic stability. Its piperidine moiety makes it valuable in designing drugs with improved pharmacokinetic properties. Researchers also explore its use in agrochemicals, particularly in the synthesis of pesticides and herbicides, where the trifluoromethyl group contributes to increased efficacy.